Zimmer Warning Letter Confirms Ongoing Issues With CAPA, Process Validation
Executive Summary
US FDA has released a six-violation warning letter sent to a Zimmer Biomet facility in Warsaw, Ind. The company had already acknowledged that the letter was a possibility.